98%
921
2 minutes
20
Studies have demonstrated that bleach baths improve atopic dermatitis (AD) severity; however, the effects on itch, skin barrier, and cutaneous microbial composition are less clear. We examined whether bleach baths reduce itch, normalize skin barrier function, reduce S. aureus absolute abundance, and increase microbial diversity in adults with AD who were colonized with S. aureus on their non-lesional skin. This was an open label, non-randomized, controlled trial performed at a single academic center. Fifteen AD and five non-atopic healthy controls (NA) were instructed to take two bleach baths (0.005% NaClO; 5-10 min duration) per week for a total of 12 weeks as add-on therapy. Adults 18 to 65 years (inclusive) with mild to severe AD were recruited with EASI score > 6.0, S. aureus culture positivity, access to a bathtub, and ability and willingness to maintain current topical or systemic treatments. They were evaluated at baseline (before bleach baths), 6 weeks, and 12 weeks after the intervention of twice-weekly bleach baths. Efficacy measurements included EASI as well as 5-D Pruritus and ItchyQoL™. Transepidermal water loss (TEWL) and stratum corneum (SC) integrity assay were performed to assess the skin barrier. Skin dysbiosis was measured by S. aureus cultivation, S. aureus abundance (qPCR of thermonuclease gene), and V1-V3 16S rRNA gene sequencing on non-lesional and lesional AD skin. After 12 weeks of bleach baths, 8/15 (53.3%) AD subjects achieved an EASI and a significant reduction in itch as measured by 5-D pruritus and Itchy QoL. Eighty-seven percent reported improvements in sleep quality. At study entry, AD subjects had higher non-lesional TEWL values than NA subjects, and only AD subjects experienced a reduction with bleach baths (p = 0.006). Similarly, SC integrity improved as early as 6 weeks after bleach baths in AD subjects. Notably, bleach baths had no significant effect on S. aureus culture-positivity, qPCR absolute abundance, or microbial diversity. The addition of twice-weekly bleach baths improves investigator-assessed AD severity, patient-reported pruritus and sleep as well as physiological measures of skin barrier function in adult AD subjects while having no effect on qualitative and quantitative measures of cutaneous S. aureus. Trial Registration: ClinicalTrials.gov Identifier: NCT01996150, Date of registration: November 27th, 2013.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615920 | PMC |
http://dx.doi.org/10.1007/s00403-023-02723-1 | DOI Listing |
Pediatr Rev
August 2025
SickKids Hospital, Toronto, Ontario, Canada.
The goal of management of atopic dermatitis (AD) or eczema, is to achieve disease control in the absence of a cure. This review aims to outline the current management and treatment of AD and explore gaps in knowledge about the effectiveness of treatment control. Although there is no concrete definition of or specific features that constitute "control" in this context, control includes reducing disease activity, decreasing symptoms, and ultimately improving quality of life.
View Article and Find Full Text PDFDermatol Pract Concept
April 2025
Institute of Dermatology, Department of Medicine, University of Udine, Udine, Italy.
Introduction: Psoriasis is a common skin disease displaying a broad spectrum of clinical presentations that can sometimes pose diagnostic challenges. UV-induced fluorescence dermatoscopy (UVFD) is a novel dermatoscopy mode useful as a complementary diagnostic method in inflammatory dermatoses. The understanding of red fluorescence in psoriasis, caused by protoporphyrin IX, in regard to clinical-morphological features, site-dependency, geographic variability, and bleaching with sun-exposure remains very limited.
View Article and Find Full Text PDFAtopic dermatitis (AD), a common chronic inflammatory skin disorder is characterized by a complex pathology with skin-barrier abnormalities, immune dysregulation, and microbial dysbiosis. Patients' quality of life is often negatively impacted by persistent pruritus, sleep disturbance, and recurrent skin infections. In addition, patients may have comorbid atopic as well as nonatopic diseases.
View Article and Find Full Text PDFWorld Allergy Organ J
December 2024
National Allergy Council, Sydney NSW, 2000, Australia.
Ultrason Sonochem
December 2024
Department of Food Science and Technology, Faculty of Agriculture, Fasa University, Fasa, Iran.
Experimental data were analyzed to investigate the underlying adsorption or degradation mechanism of carotenoids and chlorophylls over the bleaching of sunflower oil through different amplitudes of horn and bath ultrasound (ultrasound-assisted bleaching; UAB), temperature, time, and bleaching clay. Quantifying the color removal efficiency in both batch and continuous systems, along with the corresponding process time and energy consumption, is paramount for evaluating the energy-related performance of the treatment method. The adsorption of pigments onto activated bentonite was notably rapid and effective when ultrasound was employed.
View Article and Find Full Text PDF